Martinez de Andino: GLP-1 medications slow the rate at which food leaves the stomach, so GLP-1 users stay full longer and do not feel as hungry
Iron absorption is very important because iron is frequently deficient in those with kidney disease
The FDA has, however, previously raised concerns about several of the compounds
For instance, a randomized controlled trial in patients with non-alcoholic fatty liver disease (NAFLD) reported improvements in HDL cholesterol and fat-free mass, although no significant changes in liver enzymes were observed (Mohammadi et al., 2025)
It signals fullness to the brain, potentially leading to reduced food intake and weight loss
Our Memphis team provides continuous support, monitoring your progress and adjusting your plan as needed